| Product No | EMEA/H/C/002640 |
|---|---|
| Brand Name | Cometriq |
| Nonproprietary Name | cabozantinib |
| API | cabozantinib |
| ATC Code | L01XE |
| Indications | Treatment of adult patients with progressive, unresectable locally advanced or metastatic medullary thyroid carcinoma. |
| Orphan Drug | yes |
| Generics | no |
| Marketing Authorization Holder | Ipsen Pharma |
| Status | Authorised(授权) |
| Authorization Date | 2014-03-21 |
| Version | 27 |
| Condition Approval | no |
| Exceptions | no |
| Biosimilar | no |
| Details | 查看 (公众评估报告、授权细节、产品规格/剂型、标签、历史评估信息) |
Extended Information